The dawn of a cure for sickle cell disease through CRISPR-based treatment: A critical test of equity in public health genomics
Description
Equity in access to genomic technologies, resources, and products remains a great challenge. This was evident especially during the coronavirus disease 2019 (COVID-19) pandemic when the majority of lower middle-income countries were unable to achieve
